Abstract: The present invention sets forth a technique for generating two-dimensional (2D) renderings of a three-dimensional (3D) scene from an arbitrary camera position under arbitrary lighting conditions. This technique includes determining, based on a plurality of 2D representations of a 3D scene, a radiance field function for a neural radiance field (NeRF) model. This technique further includes determining, based on a plurality of 2D representations of a 3D scene, a radiance field function for a “one light at a time” (OLAT) model. The technique further includes rendering a 2D representation of the scene based on a given camera position and illumination data. The technique further includes computing a rendering loss based on the difference between the rendered 2D representation and an associated one of the plurality of 2D representations of the scene. The technique further includes modifying at least one of the NeRF and OLAT models based on the rendering loss.

Abstract: A lithium iron phosphate electrochemically active material for use in an electrode and methods and systems related thereto are disclosed. In one example, a lithium iron phosphate electrochemically active material for use in an electrode is provided including, a dopant comprising vanadium and optionally a co-dopant comprising cobalt.

Abstract: The present invention relates to neutralizing antibodies of the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing headache conditions, such as migraine and cluster headache, using the neutralizing antibodies are also described.

Abstract: Anion exchange membrane and methods of making and using the same. In one embodiment, the anion exchange membrane may be made by a method that includes a two-step polymerization. In the first step, an ?-olefin monomer containing a pendant halide, such as 8-bromo-1-octene, may be polymerized by Ziegler-Natta polymerization to form a first polymer portion, the first polymer portion being a homopolymer. In the second step, the polymerization is charged with a non-functionalized ?-olefin monomer, such as ethylene, thereby forming a second polymer portion, the second polymer being a copolymer made up predominantly of the non-functionalized olefin monomer. If desired, a small amount of an ?-olefin monomer containing a crosslinking functionality may be included in the first and/or second steps. Following the two-step polymerization, the polymer is fabricated into a thin film. Thereafter, the thin film may be functionalized by replacing the pendant halides with pendant cations.

Abstract: An activity smoothener circuit is provided to control rates of change in processing activity to limit di/dt in activity areas of an IC to mitigate voltage droops or overshoots. Controlling the rate of change of activity prevents or reduces instances of a di/dt exceeding a programmed maximum that is based on physical limits of the IC and/or a package. In examples, the activity smoothener circuit includes a hierarchy of smoothening circuits controlling activity in areas down to individual circuit blocks (tiles) including execution circuits. An indication of a desired level of activity is provided to a parent smoothening circuit and the parent smoothening circuit responds with indications of actual activity allowed to occur. At each level of hierarchy, the activity smoothener circuit may use algorithms to generate indications of actual activity based on indications of desired activity and di/dt limits. Di/dt limits and current minimums and maximums are controlled.

Abstract: A lithium iron phosphate electrochemically active material for use in an electrode and methods and systems related thereto are disclosed. In one example, a lithium iron phosphate electrochemically active material for use in an electrode is provided including, a dopant comprising vanadium and optionally a co-dopant comprising cobalt.

Abstract: When monitoring patients in a general ward, clinical decision support risk scores are evaluated to determine whether a patient should be monitored using a spot check method whereby a caregiver periodically checks the patient, a continuous monitoring method whereby the patient is monitored by a monitoring device such as an electrocardiograph, or whether the patient requires transfer to a progressive care unit (PCU) or intensive care unit (ICU). When the number of patient monitors is not sufficient to assign a monitor to all patients for whom a monitor is desired, CDS score thresholds are adjusted to ensure that the neediest patients are assigned monitors.